## Clinical Diagnosis **Key Point:** This child has stage X1A xerophthalmia (conjunctival xerosis with Bitot's spots) — an early, reversible stage of vitamin A deficiency. ## Xerophthalmia Classification | Stage | Clinical Features | Reversibility | | --- | --- | --- | | XN | Night blindness only | Fully reversible | | X1A | Conjunctival xerosis | Fully reversible | | X1B | Bitot's spots | Fully reversible | | X2 | Corneal xerosis | Fully reversible | | X3A | Corneal ulceration/scarring (< 1/3 cornea) | Partially reversible | | X3B | Corneal scarring (≥ 1/3 cornea) | Irreversible; leads to blindness | | XS | Corneal scar | Permanent blindness | ## Management Protocol **High-Yield:** WHO/ICMR guidelines for vitamin A deficiency in children recommend: 1. **Acute phase (first 2 days):** Oral vitamin A 200,000 IU daily × 2 days 2. **Follow-up dose:** Repeat the same dose after 2 weeks 3. **Route:** Oral is preferred in non-corneal stages; IM reserved for severe malabsorption or unconscious patients **Clinical Pearl:** Bitot's spots are pathognomonic for vitamin A deficiency and represent foamy, triangular patches of desquamated conjunctival epithelium. Their presence indicates systemic vitamin A depletion even though they are not sight-threatening. **Key Point:** At stage X1A, the cornea is NOT involved, so the goal is to prevent progression to corneal xerosis (X2) and ulceration (X3A/B), which cause irreversible blindness. Prompt oral supplementation halts progression. ## Why Oral Route? - Oral absorption is adequate in this child (no signs of malabsorption) - Avoids injection trauma in a young child - Compliance is easier with oral dosing - IM route is reserved for unconscious patients, severe diarrhea, or suspected malabsorption 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.